Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC.
暂无分享,去创建一个
N. Brunetti | L. Svensson | H. Bueno | K. Huber | M. Castrén | F. Beygui | M. Tubaro | E. Swahn | U. Zeymer | F. Rosell-Ortiz | F. Folke | M. Christ | N. Nikolaou | S. Charpentier | P. Goldstein | L. Nibbe | A. V. Van’t Hof | A. V. van‘t Hof
[1] J. McMurray,et al. European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care , 2017, European heart journal. Acute cardiovascular care.
[2] M. Christ,et al. Editor’s Choice- Call to action: Initiation of multidisciplinary care for acute heart failure begins in the Emergency Department , 2016, European heart journal. Acute cardiovascular care.
[3] P. Ponikowski,et al. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version. , 2015, European heart journal.
[4] Peter Cameron,et al. Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction , 2015, Circulation.
[5] Rachel Liu,et al. The "5Es" of emergency physician-performed focused cardiac ultrasound: a protocol for rapid identification of effusion, ejection, equality, exit, and entrance. , 2015, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[6] K. Eagle,et al. High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. , 2015, European heart journal.
[7] M. Almendro-Delia,et al. Prognostic impact of clopidogrel pretreatment in patients with acute coronary syndrome managed invasively. , 2015, The American journal of cardiology.
[8] G. Stone,et al. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. , 2015, JAMA.
[9] K. Nycz,et al. Validity of a 5-minute focused echocardiography with A-F mnemonic performed by non-echocardiographers in the management of patients with acute chest pain , 2015, Cardiovascular Ultrasound.
[10] S. Vanni,et al. Diagnostic performance of focused cardiac ultrasound performed by emergency physicians for the assessment of ascending aorta dilatation and aneurysm , 2015, Critical Ultrasound Journal.
[11] R. Abbate,et al. Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study. , 2015, Journal of the American College of Cardiology.
[12] A. Jaffe,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[13] Mike Fisher,et al. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial , 2014, The Lancet.
[14] A. Kirtane,et al. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors , 2014, BMJ : British Medical Journal.
[15] A. Torbicki,et al. Management of venous thrombo-embolism: an update. , 2014, European heart journal.
[16] G. Montalescot,et al. Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis , 2014, BMJ.
[17] C. Vrints,et al. The ESC Textbook of Intensive and Acute Cardiovascular Care , 2014 .
[18] Helmut Baumgartner,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[19] B. Burnand,et al. Trends of pre-hospital emergency medical services activity over 10 years: a population-based registry analysis , 2014, BMC Health Services Research.
[20] M. Sabatine,et al. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials , 2014, The Lancet.
[21] P. Chandraratna,et al. Role of Echocardiography in the Treatment of Cardiac Tamponade , 2014, Echocardiography.
[22] F. Rosell-Ortiz,et al. Initial complications and factors related to prehospital mortality in acute myocardial infarction with ST segment elevation , 2014, Emergency Medicine Journal.
[23] B. Gersh,et al. The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions. , 2014, European heart journal.
[24] K. Huber,et al. Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial , 2014, European heart journal.
[25] J. Ferrières,et al. Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy: The French Registry on Acute ST-Elevation and Non–ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort , 2014, Circulation.
[26] Talicia A Tarver. HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION , 2014 .
[27] H. White,et al. The HERO-2 ECG sub-studies in patients with ST elevation myocardial infarction: implications for clinical practice. , 2013, International journal of cardiology.
[28] S. Pocock,et al. Bivalirudin started during emergency transport for primary PCI. , 2013, The New England journal of medicine.
[29] C. Terkelsen,et al. Quantitative point-of-care troponin T measurement for diagnosis and prognosis in patients with a suspected acute myocardial infarction. , 2013, The American journal of cardiology.
[30] I. Porto,et al. Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial. , 2013, International journal of cardiology.
[31] E. Vicaut,et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. , 2013, The New England journal of medicine.
[32] Y. Adler,et al. Management of pericardial effusion. , 2013, European heart journal.
[33] R. Abbate,et al. Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. , 2013, Journal of the American College of Cardiology.
[34] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, The New England journal of medicine.
[35] Gregg W Stone,et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. , 2013, The New England journal of medicine.
[36] G. Montalescot,et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. , 2012, JAMA.
[37] C. Cairns,et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. , 2012, The American journal of emergency medicine.
[38] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[39] C. Schmidt,et al. To transmit or not to transmit: how good are emergency medical personnel in detecting STEMI in patients with chest pain? , 2012, The Canadian journal of cardiology.
[40] K. Huber,et al. Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial , 2012, Clinical Research in Cardiology.
[41] R. Ferrari,et al. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients wit , 2012, JACC. Cardiovascular interventions.
[42] E. Vicaut,et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[43] Jeroen J. Bax,et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.
[44] D. Dudek,et al. Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis , 2011, Journal of thrombosis and haemostasis : JTH.
[45] E. Vicaut,et al. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.
[46] P. Janský,et al. Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology , 2011, Acute cardiac care.
[47] David M. Williams,et al. Sensitivity of the Aortic Dissection Detection Risk Score, a Novel Guideline-Based Tool for Identification of Acute Aortic Dissection at Initial Presentation: Results From the International Registry of Acute Aortic Dissection , 2011, Circulation.
[48] C. Terkelsen,et al. Prehospital troponin T testing in the diagnosis and triage of patients with suspected acute myocardial infarction. , 2011, The American journal of cardiology.
[49] D. Ardissino,et al. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis , 2010, Circulation.
[50] A. Malmivaara,et al. Is advanced life support better than basic life support in prehospital care? A systematic review , 2010, Scandinavian journal of trauma, resuscitation and emergency medicine.
[51] John E Billi,et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.
[52] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.
[53] M. Shuster,et al. Part 1: Executive summary☆ , 2010, Resuscitation.
[54] P. Armstrong,et al. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. , 2010, European heart journal.
[55] P. Stella,et al. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome. , 2010, Journal of the American College of Cardiology.
[56] S. Halvorsen,et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.
[57] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.
[58] E. Topol,et al. 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial. , 2009, JACC. Cardiovascular interventions.
[59] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[60] E. Antman,et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.
[61] R. D. de Winter,et al. A new ECG sign of proximal LAD occlusion. , 2008, The New England journal of medicine.
[62] T. Betts,et al. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment? , 2007, Emergency Medicine Journal.
[63] K. Eagle,et al. Aortic Diameter ≥5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD) , 2007, Circulation.
[64] E. Antman,et al. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. , 2007, European heart journal.
[65] P. Armstrong,et al. Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. , 2006, American heart journal.
[66] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.
[67] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.
[68] L. Morrison,et al. Prehospital transcutaneous cardiac pacing for symptomatic bradycardia or bradyasystolic cardiac arrest: a systematic review. , 2006, Resuscitation.
[69] S. Goldhaber,et al. Acute pulmonary embolism: part II: treatment and prophylaxis. , 2006, Circulation.
[70] Salim Yusuf,et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. , 2006, The New England journal of medicine.
[71] S. Yusuf,et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. , 2006, JAMA.
[72] J. Ruskin,et al. Amiodarone is poorly effective for the acute termination of ventricular tachycardia. , 2006, Annals of emergency medicine.
[73] R. Collins,et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.
[74] B. Lewis,et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. , 2005, JAMA.
[75] R. Califf,et al. Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. , 2005, Journal of the American College of Cardiology.
[76] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[77] W John Boscardin,et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. , 2005, JAMA.
[78] W Klein,et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). , 2004, European heart journal.
[79] J Herlitz,et al. [Task Force on the management of chest pain]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[80] H. Suryapranata,et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. , 2002, Journal of the American College of Cardiology.
[81] H. White,et al. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial , 2001, The Lancet.
[82] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.
[83] T. Aufderheide,et al. The efficacy of atropine in the treatment of hemodynamically unstable bradycardia and atrioventricular block: prehospital and emergency department considerations. , 1999, Resuscitation.
[84] J. Bronzwaer,et al. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study. , 1998, Journal of the American College of Cardiology.
[85] Eric Boersma,et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.
[86] K. Schrank,et al. Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control. , 1995, The American journal of emergency medicine.
[87] G. Palmer,et al. Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia. , 1994, Annals of emergency medicine.
[88] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[89] Jeroen J. Bax,et al. [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]. , 2016, Giornale italiano di cardiologia.
[90] H. Thiele,et al. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in , 2015, JACC. Cardiovascular interventions.
[91] Jeroen J. Bax,et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .
[92] G. Montalescot,et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. , 2014, The New England journal of medicine.
[93] M. Humbert,et al. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .
[94] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[95] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[96] K. Mahaffey,et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .
[97] K. Mahaffey,et al. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ( ESC ) , 2012 .
[98] Gavin Perkins,et al. 2009 in review. , 2010, Resuscitation.
[99] B. Gersh. Facilitated PCI in Patients with ST-Elevation Myocardial Infarction , 2009 .
[100] Piotr Pruszczyk,et al. Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .
[101] M. Yacoub,et al. [Guidelines on the diagnosis and management of pericardial diseases. Executive summary]. , 2004, Revista espanola de cardiologia.
[102] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi , 2004, The Canadian journal of cardiology.
[103] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[104] Volkmar Falk,et al. Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .